Basit öğe kaydını göster

Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer

dc.contributor.authorAkisik, Ebru Esin
dc.contributor.authorSaip, Pinar
dc.contributor.authorTopuz, Erkan
dc.contributor.authorIgci, Abdullah
dc.contributor.authorOzmen, Vahit
dc.contributor.authorMuslumanoglu, Mahmut
dc.contributor.authorEralp, Yesim
dc.contributor.authorKeskin, Serkan
dc.contributor.authorAkisik, Elif
dc.contributor.authorDalay, Nejat
dc.contributor.authorTunaci, Mehtap
dc.contributor.authorYilmaz, Sabri
dc.contributor.authorCamlica, Hakan
dc.contributor.authorTuzlali, Sitki
dc.date.accessioned2021-03-04T14:37:02Z
dc.date.available2021-03-04T14:37:02Z
dc.date.issued2013
dc.identifier.citationEralp Y., Keskin S., Akisik E. E. , Akisik E., Igci A., Muslumanoglu M., Yilmaz S., Tunaci M., Camlica H., Tuzlali S., et al., "Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.36, sa.3, ss.215-223, 2013
dc.identifier.issn0277-3732
dc.identifier.othervv_1032021
dc.identifier.otherav_827afe71-4de9-4171-96f2-8693aed5eedd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/88866
dc.identifier.urihttps://doi.org/10.1097/coc.0b013e318243913f
dc.description.abstractIntroduction: The primary aim of this study is to investigate the effect of change in the expression levels of survivin, glutathione-S-transferase P1 (GSTP1), and topoisomerase 2 alpha (TOP2A) on the response to antracyclin-based and taxane-based neoadjuvant chemotherapy.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titlePredictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume36
dc.identifier.issue3
dc.identifier.startpage215
dc.identifier.endpage223
dc.contributor.firstauthorID16617


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster